Trade AMRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Amneal Pharmaceuticals, Inc. Class A (AMRX) is trading at US$18.71, up 2.35% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$6.24B. Over the past 52 weeks, AMRX has traded between US$9.49 and US$19.26. On Syfe you can trade AMRX with $0 commission and add it to your watchlist.
| Previous close | US$18.28 |
|---|---|
| Market cap | US$6.24B |
| P/E ratio | 16.33 |
| 52-week range | US$9.49 – US$19.26 |
| Volume | 6.55M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Amneal Pharmaceuticals, Inc. Class A
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.
Year: 2018
Amneal Pharmaceuticals Insider Sold Shares Worth $3,771,050, According to a Recent SEC Filing
Aug 13, 8:30 PM · MT Newswires
Amneal Pharmaceuticals Insider Sold Shares Worth $2,563,517, According to a Recent SEC Filing
Aug 13, 8:28 PM · MT Newswires
Amneal Pharmaceuticals Completes Kashiv BioSciences Acquisition
Aug 10, 1:37 PM · MT Newswires
Amneal Pharmaceuticals, Inc. Class A (AMRX) stock is trading at US$18.71, +2.35% from the previous close of US$18.28.
The market cap for Amneal Pharmaceuticals, Inc. Class A (AMRX) stock is approximately US$6.24B.
The price-to-earnings ratio for Amneal Pharmaceuticals, Inc. Class A (AMRX) is 16.33, based on the latest reported earnings.
The 52-week high for Amneal Pharmaceuticals, Inc. Class A (AMRX) stock is US$19.26.
The 52-week low for Amneal Pharmaceuticals, Inc. Class A (AMRX) stock is US$9.49.
Amneal Pharmaceuticals, Inc. Class A (AMRX) does not currently pay a dividend.
Stay on top of AMRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
